Skip to content

Clinical trials

Urogenital Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Country / region: United States Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20091
20103
20115
20123
20131
20145
20157
20161
20174
20186
20196
20208
20216
20226
20239
20246
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting23
Terminated17
Active, not recruiting14
Withdrawn3
Not yet recruiting2
Unknown status2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
M.D. Anderson Cancer Center7
Celldex Therapeutics3
Dana-Farber Cancer Institute3
Mayo Clinic3
NanOlogy, LLC3
Advanced Accelerator Applications2
Astellas Pharma Global Development, Inc.2
City of Hope Medical Center2
Duke University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms95
Prostatic Neoplasms34
Neoplasms32
Breast Neoplasms25
Neoplasms by Site23
Urinary Bladder Neoplasms20
Gastrointestinal Neoplasms19
Genital Neoplasms, Male19
Lung Neoplasms17
Melanoma17

Trials

Showing 26 to 50 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.